Abiopharma

New Form 424B3 - CytoDyn Inc. Filed: 2026-01-09 AccNo: 0001104659-26-002535 Size: 1 MB

Lee Chan Henry 🟡 adjusted position in 8.6K shares (3 derivative) of BeOne Medicines Ltd. (ONC) at $331.76 Transaction Date: Jan 07, 2026 | Filing ID: 000002

(99% Neutral) PROPHASE LABS, INC. (PRPH) Announces Business Combination

Power Sean A 🟢 acquired 90.0K shares of TG THERAPEUTICS, INC. (TGTX) Transaction Date: Jan 08, 2026 | Filing ID: 001015

RA CAPITAL MANAGEMENT, L.P. 🟡 adjusted position in 11.0M shares (4 derivative) of Cidara Therapeutics, Inc. (CDTX) at $221.50 ($1031.2M) Transaction Date: Jan 07, 2026 | Filing ID: 000031

Director Boyce Sarah 🔴 sold 8.6K shares of Avidity Biosciences, Inc. (RNA) at $72.23 Transaction Date: Jan 07, 2026 | Filing ID: 000014

Calderaro Charles III 🔴 sold 3.7K shares of Avidity Biosciences, Inc. (RNA) at $72.23 Transaction Date: Jan 07, 2026 | Filing ID: 000013

McCarthy Teresa 🔴 sold 2.0K shares of Avidity Biosciences, Inc. (RNA) at $72.23 Transaction Date: Jan 07, 2026 | Filing ID: 000012

Moriarty John B 🔴 sold 2.4K shares of Avidity Biosciences, Inc. (RNA) at $72.23 Transaction Date: Jan 07, 2026 | Filing ID: 000011

MacLean Michael F 🔴 sold 2.0K shares of Avidity Biosciences, Inc. (RNA) at $72.23 Transaction Date: Jan 07, 2026 | Filing ID: 000010

Hughes Steven George 🔴 sold 2.4K shares of Avidity Biosciences, Inc. (RNA) at $72.23 Transaction Date: Jan 07, 2026 | Filing ID: 000009

Flanagan W. Michael 🔴 sold 2.4K shares of Avidity Biosciences, Inc. (RNA) at $72.23 Transaction Date: Jan 07, 2026 | Filing ID: 000008

(99% Neutral) PROPHASE LABS, INC. (PRPH) Announces Executive Departure

New Form 3 - STRYKER CORP Filed: 2026-01-09 AccNo: 0002104636-26-000002 Size: 546 KB

New Form DEF 14A - Salarius Pharmaceuticals, Inc. Filed: 2026-01-09 AccNo: 0001193125-26-008944 Size: 863 KB